𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Persistent posttreatment depressive symptoms in patients with head and neck cancer

✍ Scribed by Lucy Hynds Karnell; Gerry F. Funk; Alan J. Christensen; Eben L. Rosenthal; J. Scott Magnuson

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
163 KB
Volume
28
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

This study examined the prevalence and risk factors of persistent (versus short‐term) depressive symptoms in patients with head and neck cancer.

Methods.

Patients with 10+ and 18+ posttreatment Beck Depression Inventory scores for 6 or more months during their first year were identified. Regression analyses determined risk factors associated with persistently high scores.

Results.

Of the 148 patients, 25.0% and 7.4% were persistently above the 10+ and 18+ cutoff scores, respectively (compared with 33.6% to 44.2% and 9.2% to 18.6% when measured at single points across this time period.) The strongest predictor of persistent posttreatment depressive symptoms was pretreatment depressive symptoms.

Conclusions.

The percentage of patients with persistently high levels of depressive symptoms, although considerable, is substantially lower when patients with transient mood disorders are omitted. A screening tool that determines high levels of pretreatment depressive symptoms could identify patients at high risk of experiencing posttreatment depression who would be good candidates for clinical intervention. Β© 2005 Wiley Periodicals, Inc. Head Neck 28: 453–461, 2006

πŸ“œ SIMILAR VOLUMES

Depressive symptoms during and after rad
Depressive symptoms during and after radiotherapy for head and neck cancer
✍ Susanne Sehlen; Marcus Lenk; Peter Herschbach; Uelker Aydemir; Marc Dellian; Bea πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 198 KB πŸ‘ 1 views

## Abstract ## Background. Patients with head and neck cancer are extraordinarily susceptible to depressive traits. Thus, a general screening of these patients at their first admission to the ital is desirable. ## Methods. From 1997–2001, 133 patients with head and neck tumors filled in the Self

Correlates of depressed mood in ambulato
Correlates of depressed mood in ambulatory head and neck cancer patients
✍ Akira Kugaya; Tatsuo Akechi; Hitoshi Okamura; Ichiro Mikami; Yosuke Uchitomi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 58 KB πŸ‘ 2 views

High levels of psychological distress, especially depressed mood, has been discussed in relation to head and neck cancer. Patients with head and neck cancer face functional impairment and disfigurement caused by cancer and/or its treatment. Psychosocial factors that predict depressed mood in this po

Second neoplasm in patients with head an
Second neoplasm in patients with head and neck cancer
✍ Xavier LeΓ³n; Miquel Quer; Santiago Diez; Cesar OrΓΊs; Antonio LΓ³pez-Pousa; Joaqui πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 2 views

Background. The improvement in locoregional control of head and neck carcinomas over the last decades does not appear to modify the final survival of these patients, mainly due to the appearance of distant metastases and second neoplasms. We ran a study to evaluate the incidence of second neoplasms

Planned postradiotherapy neck dissection
Planned postradiotherapy neck dissection in patients with advanced head and neck cancer
✍ Timothy S. Boyd; Paul M. Harari; Scott P. Tannehill; Marta C. Voytovich; Gregory πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 82 KB πŸ‘ 2 views

## Background: Metastatic neck nodes in patients with squamous cell carcinoma of the head and neck are most commonly managed by surgery, radiotherapy, or combined-modality therapy. for combined-modality cases, the sequencing of surgery and radiotherapy is generally guided by which modality is consi